COCO

Wahana Interfood Nusantara

$78.74

+6.09%
Jun 10, 2026
Bobby Quantitative Model
The Vita Coco Company, Inc. is a plant-based functional hydration platform operating in the non-alcoholic beverage industry, primarily known for its flagship Vita Coco Coconut Water brand and extensions like sparkling coconut water and coconut milk. The company has established itself as a leading brand in the coconut water category, leveraging its strong market position in the Americas, which contributes the majority of its revenue. The current investor narrative revolves around the company's successful transition to consistent profitability and robust growth, as evidenced by its recent financial performance, with significant attention on its ability to expand margins and scale its platform beyond core coconut water into adjacent categories.

People also watch

The Coca-Cola Company

The Coca-Cola Company

KO

Analysis
PepsiCo

PepsiCo

PEP

Analysis
Monster Beverage

Monster Beverage

MNST

Analysis
Keurig Dr Pepper

Keurig Dr Pepper

KDP

Analysis
Coca-Cola Consolidated, Inc.

Coca-Cola Consolidated, Inc.

COKE

Analysis

BobbyInvestment Opinion: Should I buy COCO Today?

Rating: Hold. The core thesis is that COCO's exceptional fundamental improvement is already reflected in its price and rich valuation, creating an unfavorable risk/reward profile despite strong underlying business momentum.

Supporting Evidence: The stock trades at a forward P/E of 36.7x, a significant premium to most consumer defensive peers, and a PEG ratio of 1.61 suggests it is priced for perfection. While profitability is robust (11.7% net margin) and the balance sheet is flawless (D/E 0.039), Q4 revenue growth was nearly flat at 0.39%, failing to support the growth narrative implied by the valuation. The technical picture shows the stock at 94% of its 52-week high, offering minimal near-term upside to the $79.70 resistance without a catalyst. The lack of a broad analyst consensus (only one covering) further clouds the visibility on fair value.

Risks & Conditions: The two biggest risks to the thesis are a sustained deceleration in revenue growth and a compression of its valuation multiple. This Hold rating would upgrade to a Buy if the forward P/E compressed below 25x on sustained earnings growth, or if quarterly revenue growth re-accelerated sustainably above 10% YoY. It would downgrade to a Sell if revenue growth turned negative or if the stock broke below key technical support at $46.52. Based on the current data, the stock appears overvalued relative to its near-term growth prospects.

Sign up to view all

COCO 12-Month Price Forecast

The assessment is neutral due to a clash between strong fundamentals and a fully valued stock price. The company's operational turnaround to consistent profitability and its pristine balance sheet are impressive. However, the stock's 111% annual run and premium valuation (PEG 1.61) appear to have priced in this improvement and more, while recent top-line growth has stalled. The base case of consolidation is most likely. The stance would turn bullish on evidence of revenue re-acceleration or a meaningful pullback in price. It would turn bearish on a breakdown below the $46.52 support level, signaling the end of the current uptrend.

Historical Price
Current Price $78.74
Average Target $72.5
High Target $95
Low Target $46

Wall Street consensus

Most Wall Street analysts maintain a constructive view on Wahana Interfood Nusantara's 12-month outlook, with a consensus price target around $102.36 and implied upside of +30.0% versus the current price.

Average Target

$102.36

1 analysts

Implied Upside

+30.0%

vs. current price

Analyst Count

1

covering this stock

Price Range

$63 - $102

Analyst target range

Buy
0 (0%)
Hold
0 (0%)
Sell
1 (100%)

Insufficient analyst coverage is available, with data indicating only one analyst providing estimates. This limited coverage typically signifies the stock is a smaller or mid-cap company with less institutional research focus, which can lead to higher volatility and less efficient price discovery. The single analyst estimates revenue of approximately $1.03 billion and EPS of $2.53 for the forward period, but without a consensus price target or buy/hold/sell distribution, it is impossible to gauge overall Wall Street sentiment or calculate implied upside/downside. The lack of a broad analyst cohort means investors must rely more heavily on their own fundamental and technical analysis, as the stock may be prone to larger price swings on company-specific news due to the thinner information environment.

Drowning in data?

Find the real signal!

Bulls vs Bears: COCO Investment Factors

The bull case, centered on a successful profitability transition, a fortress balance sheet, and powerful technical momentum, currently holds stronger evidence, as reflected in the stock's 111% annual gain. However, the bear case presents a compelling counter-argument focused on a rich valuation and decelerating top-line growth. The single most important tension in the investment debate is whether the company's recent margin expansion and profitability can justify its premium forward P/E of 36.7x in the face of near-flat Q4 revenue growth. The resolution of this tension—specifically, whether revenue re-accelerates or margins compress—will determine the stock's direction.

Bullish

  • Exceptional Profitability Improvement: The company has achieved a remarkable turnaround in profitability, with net margin expanding to 11.70% TTM from volatility in prior periods. This is evidenced by a 110.98% stock price surge over the past year, driven by the market's recognition of this transition from growth to profitable growth.
  • Strong Balance Sheet & Cash Flow: COCO has a pristine balance sheet with a debt-to-equity ratio of only 0.039 and a robust current ratio of 3.62, indicating minimal financial risk. The company also generates healthy free cash flow ($39.0M TTM), providing ample internal capital for reinvestment or shareholder returns.
  • Powerful Technical Momentum: The stock is in a strong uptrend, trading at 94% of its 52-week high ($79.70) and showing exceptional relative strength. It has gained 29.40% over the past 3 months versus the SPY's 10.28%, and its low beta of 0.714 suggests this rally has occurred with below-market volatility.
  • Analyst Confidence in Forward Growth: The forward P/E of 36.71x is significantly lower than the trailing P/E of 42.30x, implying the market expects substantial earnings growth. The single analyst covering the stock forecasts forward EPS of $2.53, representing a significant year-over-year increase from recent quarterly results.

Bearish

  • Valuation is Rich & Extended: The stock trades at a trailing P/E of 42.30x and a forward P/E of 36.71x, which are high multiples for a consumer staples company. The PEG ratio of 1.61 indicates the stock is priced for significant future growth that may be difficult to sustain, especially given recent modest revenue growth.
  • Recent Revenue Growth Has Stalled: Q4 2025 revenue grew only 0.39% year-over-year to $127.8M, a sharp deceleration from stronger growth in prior quarters (e.g., Q3 2025 revenue was $182.3M). This raises concerns about the near-term growth trajectory and the company's ability to meet high market expectations.
  • Price Nears All-Time High, Risk of Reversal: Trading at $75.13, the stock is just 5.7% below its 52-week high of $79.70, suggesting limited near-term upside and high susceptibility to a pullback. Technical analysis shows a recent 23.23% maximum drawdown from March highs, indicating volatility is present beneath the strong uptrend.
  • Limited Analyst Coverage & Visibility: With only one analyst providing estimates, there is a lack of consensus price targets and sentiment, leading to less efficient price discovery and potentially higher volatility. Investors have less external validation for the current valuation and growth assumptions.

COCO Technical Analysis

The stock is in a powerful, sustained uptrend, having gained 110.98% over the past year, significantly outperforming the SPY's 28.21% gain. As of the latest close at $75.13, the price is trading near the top of its 52-week range ($31.79 to $79.70), specifically at approximately 94% of that range, indicating strong momentum but also potential for overextension. The short-term momentum is exceptionally strong, with the stock up 12.22% over the past month and 29.40% over the past three months, both figures dramatically outpacing the broader market's gains of 6.31% and 10.28%, respectively, suggesting accelerating bullish sentiment. The stock's beta of 0.714 indicates it has been about 29% less volatile than the market over the measured period, which is notable given its explosive price appreciation. Key technical levels are clear, with immediate resistance at the 52-week high of $79.70 and support at the 52-week low of $31.79; a decisive breakout above $79.70 would confirm the continuation of the powerful uptrend, while a breakdown below the recent low of $46.52 (seen in late March) would signal a significant trend reversal.

Beta

0.74

0.74x market volatility

Max Drawdown

-23.2%

Largest decline past year

52-Week Range

$32-$80

Price range past year

Annual Return

+136.7%

Cumulative gain past year

PeriodCOCO ReturnS&P 500
1m+8.7%-1.9%
3m+35.8%+8.9%
6m+44.3%+6.4%
1y+136.7%+20.3%
ytd+47.3%+6.4%

Bobby - Your AI Investment Partner

Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions

COCO Fundamental Analysis

Revenue growth has been positive but modest recently, with Q4 2025 revenue of $127.8 million representing a year-over-year increase of only 0.39%; however, this follows several quarters of stronger growth, as evidenced by Q3 2025 revenue of $182.3 million. The core Vita Coco Coconut Water segment, at $102.3 million, remains the dominant revenue driver, significantly larger than the Private Label ($19.3 million) and Other ($6.2 million) segments. The company is solidly profitable, with Q4 2025 net income of $5.5 million and a trailing twelve-month net margin of 11.70%, demonstrating a successful shift from earlier periods of volatility. Gross margin for Q4 2025 was 34.88%, and the operating margin was 7.98%, showing the company's ability to convert sales into operating profit. The balance sheet is exceptionally strong, with a debt-to-equity ratio of just 0.039, indicating minimal financial leverage and low risk. The company generates healthy cash flow, with free cash flow over the trailing twelve months of $39.0 million, and boasts robust liquidity with a current ratio of 3.62, providing ample flexibility to fund operations and growth internally.

Quarterly Revenue

$127787000.0B

2025-12

Revenue YoY Growth

+0.00%

YoY Comparison

Gross Margin

+0.34%

Latest Quarter

Free Cash Flow

$39025000.0B

Last 12 Months

Revenue & Net Income Trends (2 Years)

Revenue Breakdown

Private Label
Product and Service, Other
Vita Coco Coconut Water

Open an Account, get $2 TSLA now!

Valuation Analysis: Is COCO Overvalued?

Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (P/E) ratio. The trailing P/E is 42.30x, while the forward P/E is notably lower at 36.71x, indicating the market expects significant earnings growth in the coming year. Compared to its own historical range, the current trailing P/E of 42.30x is below the extreme highs seen in recent quarters (e.g., 136.71x in Q4 2025) but remains elevated compared to levels like 20.87x in Q3 2024, suggesting the market is pricing in improved and more sustainable profitability. The stock trades at a Price-to-Sales (P/S) ratio of 4.95x and an EV/Sales of 6.43x; without a direct industry average provided, it is difficult to quantify a sector premium or discount, but these multiples reflect a growth stock valuation given the company's market position and margin profile. The PEG ratio of 1.61, based on trailing earnings, suggests the stock's valuation is somewhat rich relative to its historical growth trajectory, implying investors are paying for future growth expectations.

PE

42.3x

Latest Quarter

vs. Historical

Mid-Range

5-Year PE Range -69x~155x

vs. Industry Avg

N/A

Industry PE ~N/A*

EV/EBITDA

33.8x

Enterprise Value Multiple

Investment Risk Disclosure

Financial & Operational Risks: The primary financial risk is valuation compression, given the stock's elevated trailing P/E of 42.3x and forward P/E of 36.7x, which are high for the consumer staples sector. A slowdown in earnings growth could trigger significant multiple contraction. Operationally, revenue concentration is a key risk, with the core Vita Coco segment comprising 80% of Q4 sales; any brand fatigue or competitive incursion into the coconut water category could disproportionately impact results. While the balance sheet is strong (D/E 0.039), the company's modest Q4 revenue growth of 0.39% YoY raises execution risk against high market expectations.

Market & Competitive Risks: The stock's premium valuation (P/S 4.95x, EV/Sales 6.43x) makes it vulnerable to sector rotation out of growth-oriented consumer names, especially if interest rates remain elevated. Its low beta of 0.714 is deceptive given the 111% price surge; a reversion towards its mean valuation would likely see increased volatility. As a niche player in non-alcoholic beverages, COCO faces intense competition from larger, diversified rivals with greater marketing budgets, which could pressure its market share and margin profile over time.

Worst-Case Scenario: The worst-case scenario involves a simultaneous earnings miss and de-rating of its valuation multiple. If Q4's anemic 0.39% revenue growth persists and net margins contract from the current 11.7%, forward EPS estimates could be cut. Combined with a sector-wide rotation away from premium-priced growth stocks, the P/E could compress towards its historical low of 20.87x (seen in Q3 2024). This could drive the stock back towards its 52-week low of $31.79, representing a potential downside of approximately -58% from the current price of $75.13. A more immediate bear-case target would be the March 2026 low of $46.52, implying a -38% drawdown.

FAQ

The key risks are, in order of severity: 1) Valuation Risk: The high P/E multiples (42.3x trailing, 36.7x forward) create vulnerability to a de-rating if growth disappoints. 2) Growth Stagnation Risk: Q4 revenue grew only 0.39% YoY; a continuation would undermine the growth narrative. 3) Concentration Risk: 80% of Q4 revenue came from the core Vita Coco brand, creating over-reliance on a single product category. 4) Limited Coverage Risk: With only one analyst providing estimates, the stock may experience higher volatility and less efficient price discovery on company-specific news.

The 12-month forecast presents three scenarios with associated probabilities. The Base Case (55% probability) envisions a trading range of $65-$80, where the stock consolidates as modest growth meets a high valuation. The Bull Case (25% probability) projects a breakout to $85-$95, driven by re-accelerated revenue growth and sustained margins. The Bear Case (20% probability) sees a correction to $46-$60 if growth stalls and the valuation multiple contracts. The base case is most likely, centered on the analyst's forward EPS estimate of $2.53 and a gradual valuation compression from current elevated levels. The key assumption is that revenue growth remains in the low-single digits.

Based on the provided data, COCO appears overvalued relative to its near-term growth prospects. The primary metrics are a trailing P/E of 42.3x and a forward P/E of 36.7x, which are high for a consumer staples company. The PEG ratio of 1.61 (based on trailing earnings) further suggests the stock is expensive relative to its historical growth. While the company's profitability and balance sheet justify a premium, the market is currently paying a price that implies a significant acceleration in growth from the current near-flat revenue trajectory. Without that acceleration, the stock is vulnerable to multiple compression.

COCO is not an optimal buy at current levels for most investors. While the underlying business is strong—with an 11.7% net margin, minimal debt, and category leadership—the stock price has already appreciated 111% over the past year, trading at a rich forward P/E of 36.7x. This valuation prices in significant future growth that is not yet evident in the top line, as Q4 revenue grew only 0.39%. The risk/reward is balanced to unfavorable here. It could be a good buy for a patient, long-term investor on a meaningful pullback (e.g., towards the $60-$65 range) or upon clear evidence of re-accelerating revenue growth.

COCO is more suitable for a long-term investment horizon of 3-5 years, not short-term trading. While the stock has shown strong momentum, its current valuation requires the company to execute its platform expansion and sustain profitability over several years to justify the price. The low beta of 0.714 and lack of a dividend make it unattractive for income or low-volatility strategies. Short-term traders face the challenge of a stock trading near its 52-week high with limited analyst coverage, increasing unpredictability. Long-term investors can better weather potential volatility while betting on the company's category leadership and strong financials to eventually grow into its valuation.